127 related articles for article (PubMed ID: 17235473)
1. [Motivation and barriers to participation in clinical trials].
Gaul C; Schmidt T; Helm J; Hoyer H; Haerting J
Med Klin (Munich); 2006 Nov; 101(11):873-9. PubMed ID: 17235473
[TBL] [Abstract][Full Text] [Related]
2. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
Davison BJ; So A; Goldenberg SL; Berkowitz J; Gleave ME
BJU Int; 2008 Apr; 101(8):982-7. PubMed ID: 18005198
[TBL] [Abstract][Full Text] [Related]
3. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.
Melisko ME; Hassin F; Metzroth L; Moore DH; Brown B; Patel K; Rugo HS; Tripathy D
Clin Breast Cancer; 2005 Apr; 6(1):45-54. PubMed ID: 15899072
[TBL] [Abstract][Full Text] [Related]
4. [The psychosocial approach to the planning and implementation of vaccine trials for HIV infection].
Starace F; Embrione F; Fusco ML; Cafaro L
Ann Ist Super Sanita; 2003; 39(2):259-66. PubMed ID: 14587226
[TBL] [Abstract][Full Text] [Related]
5. Factors motivating dyspepsia patients to enter clinical research.
Rojavin MA; Downs P; Shetzline MA; Chilingerian R; Cohard-Radice M
Contemp Clin Trials; 2006 Apr; 27(2):103-11. PubMed ID: 16413229
[TBL] [Abstract][Full Text] [Related]
6. Participation and successful patient recruitment in primary care.
de Wit NJ; Quartero AO; Zuithoff AP; Numans ME
J Fam Pract; 2001 Nov; 50(11):976. PubMed ID: 11711015
[TBL] [Abstract][Full Text] [Related]
7. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates.
Grunfeld E; Zitzelsberger L; Coristine M; Aspelund F
Cancer; 2002 Oct; 95(7):1577-83. PubMed ID: 12237928
[TBL] [Abstract][Full Text] [Related]
8. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
9. Testing an alternate informed consent process.
Yates BC; Dodendorf D; Lane J; LaFramboise L; Pozehl B; Duncan K; Knodel K
Nurs Res; 2009; 58(2):135-9. PubMed ID: 19289935
[TBL] [Abstract][Full Text] [Related]
10. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
Halpern SD; Karlawish JH; Casarett D; Berlin JA; Townsend RR; Asch DA
Am Heart J; 2003 Dec; 146(6):985-92. PubMed ID: 14660989
[TBL] [Abstract][Full Text] [Related]
11. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
[TBL] [Abstract][Full Text] [Related]
12. The process of clinical trials: a model for successful clinical trial participation.
Lengacher CA; Gonzalez LL; Giuliano R; Bennett MP; Cox CE; Reintgen DS
Oncol Nurs Forum; 2001 Aug; 28(7):1115-20. PubMed ID: 11517845
[TBL] [Abstract][Full Text] [Related]
13. [Difficulties with conducting clinical trials in France].
Zannad F; Plétan Y
Therapie; 2001; 56(4):341-7. PubMed ID: 11677850
[TBL] [Abstract][Full Text] [Related]
14. Are subjects satisfied with the informed consent process? A survey of research participants.
Pope JE; Tingey DP; Arnold JM; Hong P; Ouimet JM; Krizova A
J Rheumatol; 2003 Apr; 30(4):815-24. PubMed ID: 12672205
[TBL] [Abstract][Full Text] [Related]
15. Personal physicians as study investigators: impact on patients' willingness to participate in clinical trials.
Sherber NS; Powe NR; Braunstein JB
Contemp Clin Trials; 2009 May; 30(3):227-32. PubMed ID: 19470317
[TBL] [Abstract][Full Text] [Related]
16. The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.
Kinney AY; Richards C; Vernon SW; Vogel VG
Prev Med; 1998; 27(5 Pt 1):713-9. PubMed ID: 9808803
[TBL] [Abstract][Full Text] [Related]
17. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
[TBL] [Abstract][Full Text] [Related]
18. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
Battaglia TA; Ash A; Prout MN; Freund KM
Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
[TBL] [Abstract][Full Text] [Related]
19. Retinitis pigmentosa patients' attitudes toward participation in retinal prosthesis trials.
Xia Y; Peng X; Ren Q
Contemp Clin Trials; 2012 Jul; 33(4):628-32. PubMed ID: 22465307
[TBL] [Abstract][Full Text] [Related]
20. Measuring participation in a prevention trial with parents of young children.
Garvey C; Julion W; Fogg L; Kratovil A; Gross D
Res Nurs Health; 2006 Jun; 29(3):212-22. PubMed ID: 16676341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
